US Complex And Chronic Condition Management Market Analysis
US COMPLEX AND CHRONIC CONDITION MANAGEMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
US Complex And Chronic Condition Management Market, By Disease Type (Cardiovascular Diseases, Oncology, Neurology, Diabetes, Musculoskeletal, Women’s Health/Fertility/Maternity, Chronic Obstructive Pulmonary Disease, Chronic Kidney Disease, Others), By Service (Consulting Service, Implementation Service, Education Service, Others), By End User (Healthcare Providers, Healthcare Payers, Pharmaceutical Companies, Medical Device Companies, Others)
In June 2024, Ushur, a cloud-based AI company, launched prebuilt AI-powered digital self-service solutions aimed at health plans and third-party administrators (TPAs). These solutions are designed to automate digital care navigation for two important member journeys: maternal and new baby health, as well as chronic condition management.
In May 2024, Premier, Inc a corporation focused on improving healthcare, and AstraZeneca established a strategic partnership known as Uncover CKD - Care Collective.This collaboration aims to detect patients with undiagnosed clinical chronic kidney disease (CKD), increase awareness of undiagnosed CKD among healthcare providers, and provide guidance to U.S. health systems seeking to enhance or establish strategies for CKD diagnosis, treatment, and care management.
In January 2024, Eli Lilly and Company, a pharmaceutical company, introduced LillyDirect, a new digital healthcare platform designed for patients in the U.S., for managing conditions such as obesity, migraine, and diabetes. LillyDirect provides disease management tools, personalized support, and the convenience of home delivery for certain Lilly medications through third-party pharmacy services.